Goldman Sachs
PGEN icon

Goldman Sachs’s Precigen PGEN Stock Holding History

Goldman Sachs’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-63,000
Closed -$412K – 5374
2018
Q4 		$412K Buy
+63,000
New +$706K ﹤0.01% 4475
2016
Q4 		– Sell
-400,876
Closed -$11.1M – 7028
2016
Q3 		$11.1M Sell
400,876
-725,673
-64% -$19.2M ﹤0.01% 2359
2016
Q2 		$27.5M Buy
1,126,549
+1,086,189
+2,691% +$30.8M 0.01% 1562
2016
Q1 		$1.36M Hold
40,360
– – ﹤0.01% 3816
2015
Q4 		$1.21M Buy
+40,360
New +$1.36M ﹤0.01% 4115

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs's PGEN Position: Q1 2026 in Review

Goldman Sachs increased its Precigen (PGEN) stake by 54% in Q1 2026, buying an estimated $4.83M and bringing the position to 3,350,477 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

Goldman Sachs first reported a position in PGEN in Q3 2013 and has held it in 49 quarters since. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Goldman Sachs held 3,350,477 shares of Precigen worth $13M as of Q1 2026.
  • Goldman Sachs bought 1,176,544 Precigen shares in Q1 2026, an estimated $4.83M.
  • Precigen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2839 holding.
  • Goldman Sachs first reported a position in Precigen in Q3 2013 and has held it in 49 quarters since.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.